Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
Filing tables
Filing exhibits
Related press release
KANT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (No. 333-218544 and No. 333-210521) and Form S-3 (No. 333-218545) of Proteostasis Therapeutics, Inc. of our report dated March 14, 2018 relating to the financial statements, which appears in this Form 10K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 14, 2018